Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,564
Closed -$201K – 99
2026
Q2
$201K Buy
+1,564
New +$183K 0.03% 98
2024
Q4
– Sell
-1,758
Closed -$200K – 267
2024
Q3
$200K Sell
1,758
-198
-10% -$23.5K 0.04% 94
2024
Q2
$242K Buy
1,956
+19
+1% +$2.45K 0.05% 89
2024
Q1
$256K Sell
1,937
-2
-0.1% -$247 0.07% 77
2023
Q4
$211K Buy
+1,939
New +$201K 0.06% 87
2023
Q3
– Sell
-1,937
Closed -$224K – 77
2023
Q2
$224K Buy
+1,937
New +$220K 0.07% 73
2023
Q1
– Sell
-2,200
Closed -$244K – 75
2022
Q4
$244K Buy
+2,200
New +$225K 0.09% 55
2022
Q3
– Sell
-2,200
Closed -$201K – 61
2022
Q2
$201K Buy
+2,200
New +$195K 0.07% 58

Other funds holding MRK

MFA Wealth Advisors's MRK Position: Q3 2026 in Review

MFA Wealth Advisors sold out of Merck (MRK) in Q3 2026, closing a stake of 1,564 shares — an estimated $201K sold.

MFA Wealth Advisors first reported a position in MRK in Q2 2022 and held it in 8 quarters. The position peaked at $256K in Q1 2024. 357 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • MFA Wealth Advisors reported no remaining Merck position as of Q3 2026 after selling out during the quarter.
  • MFA Wealth Advisors sold 1,564 Merck shares in Q3 2026, an estimated $201K.
  • MFA Wealth Advisors first reported a position in Merck in Q2 2022 and held it in 8 quarters.
  • MFA Wealth Advisors's Merck position peaked at $256K in Q1 2024.
  • 357 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on MFA Wealth Advisors's 13F filing for Q3 2026, filed 7 Oct 2026.